Analyst Ratings for Integra LifeSciences (IART)
IART Rating Summary
IART Price Target Summary
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$41.86 (+15%)
Avg. $ Target:
$41.86 (+15%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/11/2013 | Janney Montgomery Scott | Downgrade | Neutral (Buy) |
35.00 (52.00) |
38.38 | 36.40 | -5.16% | Details |
| 4/11/2013 | Northland Securities | Downgrade | Market Perform (Outperform) |
43.00 (N/A) |
38.38 | 36.40 | -5.16% | Details |
| 12/18/2012 | BofA/Merrill Lynch | Downgrade | Underperform (Neutral) |
N/A (N/A) |
37.73 | 36.40 | -3.53% | Details |
| 11/16/2012 | SunTrust Robinson Humphrey | New Coverage | Neutral (N/A) |
33.00 (N/A) |
36.56 | 36.40 | -0.44% | Details |
| 10/12/2012 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
39.07 | 36.40 | -6.83% | Details |
| 6/19/2012 | Argus | Upgrade | Buy (Hold) |
N/A (N/A) |
34.06 | 36.40 | 6.87% | Details |
| 2/3/2012 | ThinkEquity | New Coverage | Buy (N/A) |
37.00 (N/A) |
30.11 | 36.40 | 20.89% | Details |
| 10/6/2011 | Citi | Upgrade | Buy (N/A) |
N/A (N/A) |
34.93 | 36.40 | 4.21% | Details |
| 8/18/2011 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
39.61 | 36.40 | -8.1% | Details |
| 7/19/2011 | WJB Capital | Upgrade | Buy (N/A) |
N/A (N/A) |
46.33 | 36.40 | -21.43% | Details |
| 2/24/2011 | CL King | Upgrade | Buy (N/A) |
N/A (N/A) |
47.02 | 36.40 | -22.59% | Details |
| 1/24/2011 | RBC Capital | Downgrade | Sector Perform (N/A) |
N/A (N/A) |
48.00 | 36.40 | -24.17% | Details |
| 1/20/2011 | Northcoast Research | New Coverage | Neutral (N/A) |
N/A (N/A) |
48.48 | 36.40 | -24.92% | Details |
| 1/3/2011 | JPMorgan | Downgrade | Neutral (N/A) |
N/A (N/A) |
47.30 | 36.40 | -23.04% | Details |
| 12/3/2010 | Jefferies » Updated 2/22/2013 |
New Coverage | Buy (N/A) |
46.00 (43.00) |
45.04 | 36.40 | -19.18% | Details |
